课题基金 / 基金详情

HIV INTEGRASE SH3 INTERACTIONS

HIV INTEGRASE SH3 INTERACTIONS
HIV 整合酶 SH3 相互作用
批准号:
7355128
负责人:
MARK AYER MUESING
金额:
$0.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28

项目摘要

项目成果

MARK AYER MUESING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. HIV integrase is the virus's third enzyme (the other two are reverse transcriptase and protease). HIV uses integrase to incorporate its genes into a host cell's DNA. Inhibition of HIV integrase is an attractive therapeutic strategy since it would potentially protect healthy cells from infection thereby helping to bolster the immune system. We are currently investigating integrase SH3 interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
  • 批准号:
    8361508
  • 项目类别:
  • 资助金额:
    $6.72万
  • 财政年份:
    2011
  • 负责人:
    MARK AYER MUESING
  • 依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
  • 批准号:
    8169125
  • 项目类别:
  • 资助金额:
    $9.5万
  • 财政年份:
    2010
  • 负责人:
    MARK AYER MUESING
  • 依托单位:
Revealing the HIV-1 Interactome
海外基金